palbociclib 100 MG Oral Capsule [Ibrance]
- RxCUI
- 1601386
- RxNorm name
- palbociclib 100 MG Oral Capsule [Ibrance]
- Display name
- palbociclib 100 MG Oral Capsule [Ibrance]
- Full name
- palbociclib 100 MG Oral Capsule [Ibrance]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibrance | PALBOCICLIB | Pfizer Laboratories Div Pfizer Inc | e0e6412f-50b4-4fd4-9364-62818d121a07 | 2026-07-02 | Warnings, Adverse reactions | 1601386 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e0e6412f-50b4-4fd4-9364-62818d121a07 | palbociclib 100 MG Oral Capsule [Ibrance] | SBD | 21 | These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) capsules, for oral use Initial U.S. Approval: 2015 | 20260225 |
| e0e6412f-50b4-4fd4-9364-62818d121a07 | Ibrance 100 MG Oral Capsule | SY | 21 | These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) capsules, for oral use Initial U.S. Approval: 2015 | 20260225 |
| e0e6412f-50b4-4fd4-9364-62818d121a07 | Ibrance 100 MG Oral Capsule | PSN | 21 | These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE ® (palbociclib) capsules, for oral use Initial U.S. Approval: 2015 | 20260225 |